Evidence map›Paper›PMID 18450756›Full record

ArticleThe Journal of biological chemistry2008

Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment.

Ghada Abboud-Jarrous, Ruth Atzmon, Tamar Peretz, Carmela Palermo, Bedrick B Gadea, Johanna A Joyce, Israel Vlodavsky

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 175 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. The Key Role of Lysosomal Protease Cathepsins in Viral Infections.International journal of molecular sciences · 2022
    Review
  16. Article
  17. The Heparanase Regulatory Network in Health and Disease.International journal of molecular sciences · 2021
    Review
  18. Article
  19. Article
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Ghada Abboud-JarrousDepartment of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Ruth Atzmon
Tamar Peretz
Carmela Palermo
Bedrick B Gadea
Johanna A Joyce
Israel Vlodavsky
Hadassah Medical Center · ILMemorial Sloan Kettering Cancer Center · US

Funding

Dissecting the Function of Cysteine Cathepsins in the Tumor MicroenvironmentR01CA125162 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI JOYCE, JOHANNA · 2007 to 2011
$1.8M
Regulation of heparanase in cancer progressionR01CA106456 · NCI · TECHNION-ISRAEL INSTITUTE OF TECHNOLOGY · PI VLODAVSKY, ISRAEL · 2004 to 2013
$1.7M
NCI NIH HHS R01 CA 106456NCI NIH HHS R01 CA 125162-01
6 · The paper itself

Abstract

Heparanase is an endo-beta-d-glucuronidase that degrades heparan sulfate in the extracellular matrix and on the cell surface. Human proheparanase is produced as a latent protein of 543 amino acids whose activation involves excision of an internal linker segment (Ser(110)-Gln(157)), yielding the active heterodimer composed of 8- and 50-kDa subunits. Applying cathepsin L knock-out tissues and cultured fibroblasts, as well as cathepsin L gene silencing and overexpression strategies, we demonstrate, for the first time, that removal of the linker peptide and conversion of proheparanase into its active 8 + 50-kDa form is brought about predominantly by cathepsin L. Excision of a 10-amino acid peptide located at the C terminus of the linker segment between two functional cathepsin L cleavage sites (Y156Q and Y146Q) was critical for activation of proheparanase. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry demonstrates that the entire linker segment is susceptible to multiple endocleavages by cathepsin L, generating small peptides. Mass spectrometry demonstrated further that an active 8-kDa subunit can be generated by several alternative adjacent endocleavages, yielding the precise 8-kDa subunit and/or slightly elongated forms. Altogether, the mode of action presented here demonstrates that processing and activation of proheparanase can be brought about solely by cathepsin L. The critical involvement of cathepsin L in proheparanase processing and activation offers new strategies for inhibiting the prometastatic, proangiogenic, and proinflammatory activities of heparanase.

Indexed as

Gene Expression Regulation, EnzymologicAmino Acid SequenceBinding SitesCathepsin LCathepsinsCell Line, TumorCysteine EndopeptidasesFibroblastsGene SilencingGlucuronidaseHeparanaseHumansMass SpectrometryMolecular Sequence DataProtein BindingProtein Structure, TertiaryCathepsin LCathepsinsCTSL protein, humanCysteine EndopeptidasesGlucuronidaseHeparanaseRNA, Small Interfering

Identifiers

PMID18450756
PMCPMC2440611
OpenAlexW2011229547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.